AI In Biotechnology Global Market Report 2025: Unprecedented Growth Driven By Technological Advancement

June 11, 2025 02:54 AM AEST | By EIN Presswire
 AI In Biotechnology Global Market Report 2025: Unprecedented Growth Driven By Technological Advancement
Image source: EIN Presswire

LONDON, GREATER LONDON, UNITED KINGDOM, June 10, 2025 /EINPresswire.com/ -- The Business Research Company’s Latest Report Explores Market Driver, Trends, Regional Insights - Market Sizing & Forecasts Through 2034

The AI in biotechnology market size has grown exponentially in recent years. Projected to escalate from $4.46 billion in 2024 to $5.56 billion in 2025, achieving a compound annual growth rate CAGR of 24.8%, the market's impressive growth can be attributed to increasing computational power, growth of AI-driven drug discovery, growth of AI in microbiome research, rise of AI in regenerative medicine, and increasing use of AI in agricultural biotechnology.

What's Fueling The Growth Of The AI In Biotechnology Market Going Forward?

Anticipating significant growth in the next few years, the AI in biotechnology market size is projected to hit $13.40 billion in 2029, at a CAGR of 24.6%. This expected growth in the forecast period is driven by the rising adoption of AI, increasing investment in AI-biotech startups, growing adoption of AI in toxicology studies, the rise of AI-driven predictive models for cancer research, and the growth of AI-driven drug repurposing. Additionally, advancements in deep learning and neural networks, integration of AI in genomics and proteomics, advancements in AI-driven CRISPR gene editing, AI integration in pharmacovigilance, and the development of AI-based companion diagnostics are expected to shape the market trends in the forecast period.

Get Your Free Sample Market Report:
https://www.thebusinessresearchcompany.com/sample_request?id=23609&type=smp

What’s Driving The AI In Biotechnology Market Growth?

The increasing adoption of AI is expected to continue propelling the growth of the AI in biotechnology market. Artificial intelligence, the simulation of human intelligence processes by machines, particularly computer systems, enhances efficiency, accuracy, and decision-making across industries. It enables the automation of complex data analysis, ensuring consistent precision. Within the biotechnology sector, AI accelerates drug discovery, optimizes research processes, and facilitates advanced predictive modeling for improved healthcare outcomes.

What Key Player Strategies Are Driving The AI In Biotechnology Market?

In the AI in biotechnology market, key players include Google LLC, Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., International Business Machines Corporation IBM, Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca Plc, Abbott Laboratories, Novartis AG, Roivant Sciences Ltd., Gilead Sciences Inc., NVIDIA Corporation, Amgen Inc., Novo Nordisk A/S, Merck KGaA, Biogen Inc., CareDx Inc., Clario Inc., BenevolentAI Limited, Recursion Pharmaceuticals Inc., Insilico Medicine Inc., and Genesis Therapeutics Inc. These companies are paving the way for revolutionary advancements in biotechnology by utilizing artificial intelligence.

Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/ai-in-biotechnology-global-market-report

What Are The Emerging Trends In The AI In Biotechnology Market?

A recent emerging trend in the AI in biotechnology market is the development of AI-powered antibody discovery platforms. This technology-driven system utilizes artificial intelligence to rapidly identify and optimize therapeutic antibodies, facilitating faster, more cost-effective drug development and improved biopharmaceutical outcomes. In February 2023, AION Labs, an Israel-based venture studio, launched DenovAI, a platform for de novo discovery of therapeutic antibodies. Combining machine learning with computational biophysics, DenovAI allows for enhanced precision, broader sequence diversity, and significantly reduced development timelines.

How Is The AI In Biotechnology Market Segmented?

In terms of market segmentation, the AI in biotechnology market report has outlined the following:
1 By Component: Software, Hardware, Services
2 By Application: Drug Discovery And Development, Clinical Trials And Optimization, Medical Imaging, Diagnostics, Other Applications
3 By End User: Pharmaceutical Companies, Biotechnology Companies, Academic And Research Institutes, Healthcare Providers, Contract Research Organization CRO And Contract Development And Manufacturing Organization CDMO, Other End Users

What Are The Regional Insights In The AI In Biotechnology Market?

With respect to regional insights, North America holds the position of the largest region in the AI in biotechnology market as of 2024. Asia-Pacific, however, is expected to be the fastest-growing region in the predicted period. The regions covered in the AI in biotechnology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:
AI In Telecommunication Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/ai-in-telecommunication-global-market-report
AI In Medical Imaging Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/ai-in-medical-imaging-global-market-report
AI In Energy Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/ai-in-energy-global-market-report

About The Business Research Company
The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. With over 15000+ reports from 27 industries covering 60+ geographies, we provide a unique combination of in-depth secondary research and unique insights from industry leaders.

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
[email protected]
Visit us on social media:
LinkedIn
Facebook
X

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.